Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05148559 · ClinicalTrials.gov registry record · NA
Impact of Adolescent Vaccine Reminder Notices Sent Via Preferred Method of Communication on HPV Vaccination
A NA study of Papillomavirus Vaccines, sponsored by Huong Nguyen, PhD.
- Active
- Registry status
- NA
- Development phase
- 5,451
- Enrollment target
- 1
- Study location
NCT05148559: Active NA study of Papillomavirus Vaccines, sponsored by Huong Nguyen, PhD.
NCT05148559 is a NA study of Papillomavirus Vaccines that is active but no longer recruiting, run by Huong Nguyen, PhD. The registered enrollment target is 5,451 participants, above the 2,549-participant average among 4 other Papillomavirus Vaccines trials with a reported enrollment target (114% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05148559, a NA study of Papillomavirus Vaccines, is active but no longer recruiting, sponsored by Huong Nguyen, PhD.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 5,451 participants
- Enrollment target
- 1
- Study location
Study Summary
Vaccine uptake in the United States is lower in rural areas, especially for HPV vaccine. Reminder/recall has been identified as an effective strategy to increase vaccination rates. This study will assess the impact by rurality of vaccine reminder notices sent via the parent's preferred method of communication on HPV vaccination among 12 year-old patients in a regional healthcare system.
Primary Outcome
Receipt of 1 dose of HPV vaccine within 90 days of receipt of reminder (yes/no) will be assessed using vaccination data available from the Marshfield Clinic Health System electronic health record, which includes vaccinations administered outside of MCHS through data exchanges with the Wisconsin Immunization Registry. Specifically patients will be classified as having received 1 dose of HPV vaccine if they have record of receipt of HPV vaccine with a vaccination date during the 90-day follow-up p
Conditions Studied
Interventions
- BEHAVIORAL Reminder Sent Via Preferred Method of Communication
- BEHAVIORAL Reminder Sent Via Mailed Letter
Study Locations (1)
Wisconsin
- Marshfield Clinic Health System - Marshfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,451 participants |
| Start Date | 2021-08-12 |
| Est. Completion | 2026-12 |
| Phase | NA |
What the registry record for NCT05148559 still lists
NCT05148559 is an interventional study that assigns participants to a tested intervention. Its 5,451 participants enrollment target places it among the larger protocols in the corpus, above the 2,549-participant average among 4 other Papillomavirus Vaccines trials with a reported enrollment target (114% higher).
The record links to 1 condition, with Papillomavirus Vaccines appearing as the primary indexed condition, and to 2 interventions - of which Reminder Sent Via Preferred Method of Communication is the first listed.
NCT05148559 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05148559 about?
NCT05148559 is a clinical study titled "Impact of Adolescent Vaccine Reminder Notices Sent Via Preferred Method of Communication on HPV Vaccination". Vaccine uptake in the United States is lower in rural areas, especially for HPV vaccine. Reminder/recall has been identified as an effective strategy to increase vaccination rates. This study will assess the impact by rurality of vaccine reminder notices sent via the parent's preferred method of com...
What is the current status of trial NCT05148559?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 5,451 participants. The study started on 2021-08-12. Estimated completion is 2026-12.
What conditions does trial NCT05148559 study?
This clinical trial studies the following conditions: Papillomavirus Vaccines.
What interventions are being tested in trial NCT05148559?
The interventions under investigation include: Reminder Sent Via Preferred Method of Communication (BEHAVIORAL), Reminder Sent Via Mailed Letter (BEHAVIORAL).
Who is sponsoring clinical trial NCT05148559?
This trial is sponsored by Huong Nguyen, PhD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05148559 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Papillomavirus Vaccines
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention
RECRUITING · NA
-
Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors
ACTIVE NOT RECRUITING · NA
-
Let's K-Talk - HPV Study for Ethnic Koreans
ACTIVE NOT RECRUITING · NA
-
Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04295486 · 5,478 participants · Phase 2
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
- NCT05722769 · 5,408 participants · NA
CSTOP Now! Child Sex Trafficking Stops With You
- NCT05952557 · 5,500 participants · Phase 3
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
- NCT06084234 · 5,500 participants · Phase 4
National Liver Cancer Screening Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI